UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.061

Sortiert nach

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

The Lancet (British edition), 2023-09, Vol.402 (10408), p.1133-1146

2023

Link zum Volltext

Verfügbarkeit prüfen

Dual-targeted nano-encapsulation of neonatal porcine islet-like cell clusters with triiodothyronine-loaded bifunctional polymersomes

Discover nano, 2024-02, Vol.19 (1), p.23-23, Article 23

2024

Link zum Volltext

Verfügbarkeit prüfen

Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer

Scientific reports, 2023-06, Vol.13 (1), p.9928-9928, Article 9928

2023

Link zum Volltext

Verfügbarkeit prüfen

Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study

BMC cancer, 2022-09, Vol.22 (1), p.1-948, Article 948

2022

Link zum Volltext

Verfügbarkeit prüfen

Factors to improve distress and fatigue in Cancer survivorship; further understanding through text analysis of interviews by machine learning

BMC cancer, 2021-06, Vol.21 (1), p.741-16, Article 741

2021

Link zum Volltext

Verfügbarkeit prüfen

Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data

BMC cancer, 2021-03, Vol.21 (1), p.325-325, Article 325

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of surgical resection before palliative chemotherapy in advanced gastric cancer

Scientific reports, 2019-03, Vol.9 (1), p.4136-4136, Article 4136

2019

Link zum Volltext

Verfügbarkeit prüfen

Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia

Annals of hematology, 2021-11, Vol.100 (11), p.2825-2830

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer

Frontiers in oncology, 2021-03, Vol.10, p.558760-558760

2021

Link zum Volltext

Verfügbarkeit prüfen

Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma

PloS one, 2014-03, Vol.9 (3), p.e91263-e91263

2014

Link zum Volltext

Verfügbarkeit prüfen

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin

The Korean journal of internal medicine, 2022-11, Vol.37 (6), p.1269-1269

2022

Link zum Volltext

Verfügbarkeit prüfen

Radiation Therapy–First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (3), p.621-627

2016

Link zum Volltext

Verfügbarkeit prüfen

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin

The Korean Journal of Internal Medicine, 2022, 37(3), , pp.653-659

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07

Thoracic cancer, 2020-12, Vol.11 (12), p.3482-3489

2020

Link zum Volltext

Verfügbarkeit prüfen

High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy

International journal of hematology, 2016-02, Vol.103 (2), p.210-218

2016

Link zum Volltext

Verfügbarkeit prüfen

Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

Journal of clinical oncology, 2020-02, Vol.38 (5), p.488-495

2020

Link zum Volltext

Verfügbarkeit prüfen

Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection

International journal of cancer, 2012-02, Vol.130 (4), p.948-958

2012

Link zum Volltext

Verfügbarkeit prüfen

5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection

Onkologie, 2013-08, Vol.36 (7-8), p.421

2013

Link zum Volltext

Verfügbarkeit prüfen

Differential efficacy of tyrosine kinase inhibitors (TKIs) according to the types of EGFR mutations and agents in non-small cell lung cancer (NSCLC): A real-world study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21040-e21040

2023

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Flavonoid Production in Streptomyces venezuelae via Metabolic Engineering

Journal of Microbiology and Biotechnology, 2011, 21(11), , pp.1143-1146

2011

Link zum Volltext

Verfügbarkeit prüfen

A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)

European journal of cancer (1990), 2023-11, Vol.193, p.113312-113312, Article 113312

2023

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Flavonoid Production in Streptomyces venezuelae via Metabolic Engineering

Journal of microbiology and biotechnology, 2011-11, Vol.21 (11), p.1143-1146

2011

Link zum Volltext

Verfügbarkeit prüfen

Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20616-e20616

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.061

Suche als RSS-Feed

Aktive Filter

ThemaRetrospective Studies

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(961)
Mit Volltextzugriff
(1.001)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

Dual-targeted nano-encapsulation of neonatal porcine islet-like cell clusters with triiodothyronine-loaded bifunctional polymersomes

Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer

Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study

Factors to improve distress and fatigue in Cancer survivorship; further understanding through text analysis of interviews by machine learning

Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data

Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18–14/KM10B)

The role of surgical resection before palliative chemotherapy in advanced gastric cancer

Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia

Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer

Expression microarray analysis reveals alternative splicing of LAMA3 and DST genes in head and neck squamous cell carcinoma

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin

Radiation Therapy–First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer

Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin

Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07

High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy

Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection

5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection

Differential efficacy of tyrosine kinase inhibitors (TKIs) according to the types of EGFR mutations and agents in non-small cell lung cancer (NSCLC): A real-world study

Enhanced Flavonoid Production in Streptomyces venezuelae via Metabolic Engineering

A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)

Enhanced Flavonoid Production in Streptomyces venezuelae via Metabolic Engineering

Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?

Aktive Filter

Suchergebnisse filtern